羅麗芬-KY

-0.85 (-1.90%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

44.0057成交張數12.90本益比1.15股價淨值比4.55%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

元

負債總額 / 資產總額

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	26	18	27.8%	1.57	38.34	9.6%	6.8%	1.0	0.9
2026Q1	22	18	19.9%	2.30	37.23	5.8%	4.4%	-1.0	-1.0
2025Q4	23	17	25.1%	1.88	35.90	6.8%	5.0%	1.0	1.0
2025Q3	22	16	24.4%	1.89	34.44	6.8%	5.1%	0.2	0.1
2025Q2	22	15	28.4%	1.57	32.42	7.1%	5.0%	2.5	2.5
2025Q1	24	17	25.2%	2.11	36.71	5.5%	4.2%	1.3	1.2
2024Q4	23	17	23.9%	2.19	35.42	4.9%	3.7%	-2.0	-2.1
2024Q3	23	17	23.2%	2.39	35.96	5.5%	4.2%	1.8	1.8
2024Q2	23	16	27.1%	2.01	34.71	4.9%	3.5%	3.0	3.0
2024Q1	21	16	21.4%	2.67	34.76	5.4%	4.1%	0.5	0.4
2023Q4	21	16	23.2%	2.61	33.87	5.5%	4.2%	-0.6	-0.7
2023Q3	21	16	20.6%	3.09	34.51	4.0%	3.0%	0.7	0.6
2023Q2	21	16	25.1%	2.71	33.16	3.7%	2.7%	2.2	2.0
2023Q1	21	16	21.9%	3.93	34.12	3.3%	2.5%	-0.8	-1.0
2022Q4	21	16	24.5%	3.87	33.67	3.4%	2.6%	3.3	3.1
2022Q3	23	16	26.5%	3.58	34.69	6.4%	4.8%	1.1	1.0
2022Q2	22	16	26.0%	3.69	34.31	5.6%	4.4%	-2.2	-2.5
2022Q1	21	17	20.7%	5.28	35.25	4.3%	3.5%	-0.1	-0.6
2021Q4	20	16	20.0%	4.29	33.76	4.3%	3.4%	0.7	0.6
2021Q3	20	16	22.5%	3.20	32.97	7.1%	5.6%	-1.1	-1.5
2021Q2	20	17	17.7%	4.28	34.97	8.5%	6.4%	3.7	1.0
2021Q1	21	16	19.8%	4.60	34.65	6.9%	5.7%	-1.1	-1.3
2020Q4	21	16	21.0%	4.23	34.55	6.0%	4.9%	0.7	0.6
2020Q3	19	15	18.8%	5.01	32.53	10.7%	8.9%	-0.9	-1.2
2020Q2	21	15	30.0%	2.86	31.52	15.6%	11.1%	1.2	1.1
2020Q1	22	18	14.6%	7.11	38.76	21.0%	17.7%	-0.8	-1.7
2019Q4	22	18	15.8%	5.00	39.00	28.1%	23.1%	1.4	1.3
2019Q3	21	17	15.7%	4.94	36.74	–	–	-2.4	-2.8
2019Q2	23	17	27.4%	2.67	39.06	–	–	1.0	0.9
2019Q1	22	18	16.2%	4.47	42.48	–	–	0.1	0.0